Ehrlichioses and Anaplasmosis

Tropical Infectious Diseases

Volumn , Issue , 2011, Pages 339-343

  Dumler, J Stephen ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885158431     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7020-3935-5.00052-5     Document Type: Chapter

References (192)

1. Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis 2007, 45(suppl 1):S45.
2. Olano JP, Walker DH Human ehrlichioses. Med Clin North Am 2002, 86(2):375.
3. Dumler JS, Barbet AF, Bekker CP, et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and 'HGE agent' as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol 2001, 51(Pt 6):2145.
4. Perez M, Rikihisa Y, Wen B Ehrlichia canis-like agent isolated from a man in Venezuela: antigenic and genetic characterization. J Clin Microbiol 1996, 34(9):2133.
5. Buller RS, Arens M, Hmiel SP, et al. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med 1999, 341(3):148.
6. Paddock CD, Childs JE Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin Microbiol 2003, 16(1):37.
7. Inokuma H, Brouqui P, Drancourt M, et al. Citrate synthase gene sequence: a new tool for phylogenetic analysis and identification of Ehrlichia. J Clin Microbiol 2001, 39(9):3031.
8. Taillardat-Bisch AV, Raoult D, Drancourt M RNA polymerase beta-subunit-based phylogeny of Ehrlichia spp., Anaplasma spp., Neorickettsia spp. and Wolbachia pipientis. Int J Syst Evol Microbiol 2003, 53(Pt 2):455.
9. Anderson BE, Dawson JE, Jones DC, et al. Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J Clin Microbiol 1991, 29(12):2838.
10. Dawson JE, Anderson BE, Fishbein DB, et al. Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis. J Clin Microbiol 1991, 29(12):2741.
11. Chen SM, Dumler JS, Bakken JS, et al. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 1994, 32(3):589.
12. Bakken JS, Dumler JS, Chen SM, et al. Human granulocytic ehrlichiosis in the upper midwest United States. A new species emerging?. JAMA 1994, 272(3):212.
13. Paddock CD, Folk SM, Shore GM, et al. Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. Clin Infect Dis 2001, 33(9):1586.
14. Taylor MJ, Cross HF, Bilo K Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria. J Exp Med 2000, 191(8):1429.
15. Perez M, Bodor M, Zhang C, et al. Human infection with Ehrlichia canis accompanied by clinical signs in Venezuela. Ann N Y Acad Sci 2006, 1078:110.
16. Barnewall RE, Rikihisa Y, Lee EH Ehrlichia chaffeensis inclusions are early endosomes which selectively accumulate transferrin receptor. Infect Immun 1997, 65(4):1455.
17. Webster P, IJdo JW, Chicoine LM, et al. The agent of human granulocytic ehrlichiosis resides in an endosomal compartment. J Clin Invest 1998, 101(9):1932.
18. Wells MY, Rikihisa Y Lack of lysosomal fusion with phagosomes containing Ehrlichia risticii in P388D1 cells: abrogation of inhibition with oxytetracycline. Infect Immun 1988, 56(12):3209.
19. Barnewall RE, Ohashi N, Rikihisa Y Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1. Infect Immun 1999, 67(5):2258.
20. Brayton KA, Knowles DP, McGuire TC, et al. Efficient use of a small genome to generate antigenic diversity in tick-borne ehrlichial pathogens. Proc Natl Acad Sci USA 2001, 98(7):4130.
21. Scorpio DG, Caspersen K, Ogata H, et al. Restricted changes in major surface protein-2 (msp2) transcription after prolonged in vitro passage of Anaplasma phagocytophilum. BMC Microbiol 2004, 4:1.
22. Long SW, Zhang XF, Qi H, et al. Antigenic variation of Ehrlichia chaffeensis resulting from differential expression of the 28-kilodalton protein gene family. Infect Immun 2002, 70(4):1824.
23. Anderson BE, Sims KG, Olson JG, et al. Amblyomma americanum: a potential vector of human ehrlichiosis. Am J Trop Med Hyg 1993, 49(2):239.
24. Macleod JR, Gordon WS Studies in tick-borne fever of sheep. I. Transmission by the tick, Ixodes ricinus, with a description of the disease produced. Parasitology 1933, 25:273.
25. Richter PJ, Kimsey RB, Madigan JE, et al. Ixodes pacificus (Acari: Ixodidae) as a vector of Ehrlichia equi (Rickettsiales: Ehrlichieae). J Med Entomol 1996, 33(1):1.
26. Telford SR, Dawson JE, Katavolos P, et al. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc Natl Acad Sci USA 1996, 93(12):6209.
27. Martin ME, Caspersen K, Dumler JS Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis. Am J Pathol 2001, 158(5):1881.
28. Sehdev AE, Dumler JS Hepatic pathology in human monocytic ehrlichiosis. Ehrlichia chaffeensis infection. Am J Clin Pathol 2003, 119(6):859.
29. Ismail N, Soong L, McBride JW, et al. Overproduction of TNF-alpha by CD8+ type 1 cells and down-regulation of IFN-gamma production by CD4+ Th1 cells contribute to toxic shock-like syndrome in an animal model of fatal monocytotropic ehrlichiosis. J Immunol 2004, 172(3):1786.
30. Dawson JE, Fishbein DB, Eng TR, et al. Diagnosis of human ehrlichiosis with the indirect fluorescent antibody test: kinetics and specificity. J Infect Dis 1990, 162(1):91.
31. Goodman JL, Nelson C, Vitale B, et al. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med 1996, 334(4):209.
32. Walls JJ, Aguero-Rosenfeld M, Bakken JS, et al. Inter- and intralaboratory comparison of Ehrlichia equi and human granulocytic ehrlichiosis (HGE) agent strains for serodiagnosis of HGE by the immunofluorescent-antibody test. J Clin Microbiol 1999, 37(9):2968.
33. Munderloh UG, Madigan JE, Dumler JS, et al. Isolation of the equine granulocytic ehrlichiosis agent, Ehrlichia equi, in tick cell culture. J Clin Microbiol 1996, 34(3):664.
34. Popov VL, Han VC, Chen SM, et al. Ultrastructural differentiation of the genogroups in the genus Ehrlichia. J Med Microbiol 1998, 47(3):235.
35. Popov VL, Yu X, Walker DH The 120 kDa outer membrane protein of Ehrlichia chaffeensis: preferential expression on dense-core cells and gene expression in Escherichia coli associated with attachment and entry. Microb Pathog 2000, 28(2):71.
36. Miura K, Rikihisa Y Virulence potential of Ehrlichia chaffeensis strains of distinct genome sequences. Infect Immun 2007, 75(7):3604.
37. Chen SM, Dumler JS, Feng HM, et al. Identification of the antigenic constituents of Ehrlichia chaffeensis. Am J Trop Med Hyg 1994, 50(1):52.
38. Rikihisa Y, Ewing SA, Fox JC Western immunoblot analysis of Ehrlichia chaffeensis, E. canis, or E. ewingii infections in dogs and humans. J Clin Microbiol 1994, 32(9):2107.
39. Chen SM, Yu XJ, Popov VL, et al. Genetic and antigenic diversity of Ehrlichia chaffeensis: comparative analysis of a novel human strain from Oklahoma and previously isolated strains. J Infect Dis 1997, 175(4):856.
40. Kumagai Y, Huang H, Rikihisa Y Expression and porin activity of p28 and Omp-1f during intracellular Ehrlichia chaffeensis development. J Bacteriol 2008, 190(10):3597.
41. Yabsley MJ, Little SE, Sims EJ, et al. Molecular variation in the variable-length PCR target and 120-kilodalton antigen genes of Ehrlichia chaffeensis from white-tailed deer (Odocoileus virginianus). J Clin Microbiol 2003, 41(11):5202.
42. Lin M, Rikihisa Y Obligatory intracellular parasitism by Ehrlichia chaffeensis and Anaplasma phagocytophilum involves caveolae and glycosylphosphatidylinositol-anchored proteins. Cell Microbiol 2003, 5(11):809.
43. Bao W, Kumagai Y, Niu H, et al. Four Virb6 paralogs and Virb9 are expressed and interact in Ehrlichia chaffeensis-containing vacuoles. J Bacteriol 2009, 191(1):278.
44. Zhu B, Nethery KA, Kuriakose JA, et al. Nuclear translocated Ehrlichia chaffeensis ankyrin protein interacts with the mid A-stretch of host promoter and intronic Alu elements. Infect Immun 2009, 77:4243.
45. Maeda K, Markowitz N, Hawley RC, et al. Human infection with Ehrlichia canis, a leukocytic rickettsia. N Engl J Med 1987, 316(14):853.
46. Dawson JE, Childs JE, Biggie KL, et al. White-tailed deer as a potential reservoir of Ehrlichia spp. J Wildl Dis 1994, 30(2):162.
47. Dawson JE, Stallknecht DE, Howerth EW, et al. Susceptibility of white-tailed deer (Odocoileus virginianus) to infection with Ehrlichia chaffeensis, the etiologic agent of human ehrlichiosis. J Clin Microbiol 1994, 32(11):2725.
48. Lockhart JM, Davidson WR, Dawson JE, et al. Temporal association of Amblyomma americanum with the presence of Ehrlichia chaffeensis reactive antibodies in white-tailed deer. J Wildl Dis 1995, 31(2):119.
49. Dawson JE, Ewing SA Susceptibility of dogs to infection with Ehrlichia chaffeensis, causative agent of human ehrlichiosis. Am J Vet Res 1992, 53(8):1322.
50. Dawson JE, Biggie KL, Warner CK, et al. Polymerase chain reaction evidence of Ehrlichia chaffeensis, an etiologic agent of human ehrlichiosis, in dogs from southeast Virginia. Am J Vet Res 1996, 57(8):1175.
51. Breitschwerdt EB, Hegarty BC, Hancock SI Sequential evaluation of dogs naturally infected with Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia equi, Ehrlichia ewingii, or Bartonella vinsonii. J Clin Microbiol 1998, 36(9):2645.
52. Fishbein DB, Kemp A, Dawson JE, et al. Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients. J Infect Dis 1989, 160(5):803.
53. Carpenter CF, Gandhi TK, Kong LK, et al. The incidence of ehrlichial and rickettsial infection in patients with unexplained fever and recent history of tick bite in central North Carolina. J Infect Dis 1999, 180(3):900.
54. Olano JP, Masters E, Hogrefe W, et al. Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis 2003, 9(12):1579.
55. Brouqui P, Le Cam C, Kelly PJ, et al. Serologic evidence for human ehrlichiosis in Africa. Eur J Epidemiol 1994, 10(6):695.
56. Morais JD, Dawson JE, Greene C, et al. First European case of ehrlichiosis. Lancet 1991, 338(8767):633.
57. Uhaa IJ, MacLean JD, Greene CR, et al. A case of human ehrlichiosis acquired in Mali: clinical and laboratory findings. Am J Trop Med Hyg 1992, 46(2):161.
58. Ravyn MD, Korenberg EI, Oeding JA, et al. Monocytic Ehrlichia in Ixodes persulcatus ticks from Perm, Russia. Lancet 1999, 353(9154):722.
59. Park JH, Heo EJ, Choi KS, et al. Detection of antibodies to Anaplasma phagocytophilum and Ehrlichia chaffeensis antigens in sera of Korean patients by western immunoblotting and indirect immunofluorescence assays. Clin Diagn Lab Immunol 2003, 10(6):1059.
60. Yevich SJ, Sanchez JL, DeFraites RF, et al. Seroepidemiology of infections due to spotted fever group rickettsiae and Ehrlichia species in military personnel exposed in areas of the United States where such infections are endemic. J Infect Dis 1995, 171(5):1266.
61. Unver A, Rikihisa Y, Ohashi N, et al. Western and dot blotting analyses of Ehrlichia chaffeensis indirect fluorescent-antibody assay-positive and -negative human sera by using native and recombinant E. chaffeensis and E. canis antigens. J Clin Microbiol 1999, 37(12):3888.
62. Fishbein DB, Dawson JE, Robinson LE Human ehrlichiosis in the United States, 1985 to 1990. Ann Intern Med 1994, 120(9):736.
63. Marshall GS, Jacobs RF, Schutze GE, et al. Ehrlichia chaffeensis seroprevalence among children in the southeast and south-central regions of the United States. Arch Pediatr Adolesc Med 2002, 156(2):166.
64. Dunn BE, Monson TP, Dumler JS, et al. Identification of Ehrlichia chaffeensis morulae in cerebrospinal fluid mononuclear cells. J Clin Microbiol 1992, 30(8):2207.
65. Dimmitt DC, Fishbein DB, Dawson JE Human ehrlichiosis associated with cerebrospinal fluid pleocytosis: A case report. Am J Med 1989, 87(6):677.
66. Ratnasamy N, Everett ED, Roland WE, et al. Central nervous system manifestations of human ehrlichiosis. Clin Infect Dis 1996, 23(2):314.
67. Fichtenbaum CJ, Peterson LR, Weil GJ Ehrlichiosis presenting as a life-threatening illness with features of the toxic shock syndrome. Am J Med 1993, 95(4):351.
68. Dumler JS, Sutker WL, Walker DH Persistent infection with Ehrlichia chaffeensis. Clin Infect Dis 1993, 17(5):903.
69. Smith Sehdev AE, Sehdev PS, Jacobs R, et al. Human monocytic ehrlichiosis presenting as acute appendicitis during pregnancy. Clin Infect Dis 2002, 35(9):e99.
70. Safdar N, Love RB, Maki DG Severe Ehrlichia chaffeensis infection in a lung transplant recipient: a review of ehrlichiosis in the immunocompromised patient. Emerg Infect Dis 2002, 8(3):320.
71. Tan HP, Dumler JS, Maley WR, et al. Human monocytic ehrlichiosis: an emerging pathogen in transplantation. Transplantation 2001, 71(11):1678.
72. Marty AM, Dumler JS, Imes G, et al. Ehrlichiosis mimicking thrombotic thrombocytopenic purpura. Case report and pathological correlation. Hum Pathol 1995, 26(8):920.
73. Walker DH, Dumler JS Human monocytic and granulocytic ehrlichioses. Discovery and diagnosis of emerging tick-borne infections and the critical role of the pathologist. Arch Pathol Lab Med 1997, 121(8):785.
74. Dumler JS, Dawson JE, Walker DH Human ehrlichiosis: hematopathology and immunohistologic detection of Ehrlichia chaffeensis. Hum Pathol 1993, 24(4):391.
75. Lin M, Zhu MX, Rikihisa Y Rapid activation of protein tyrosine kinase and phospholipase C-gamma2 and increase in cytosolic free calcium are required by Ehrlichia chaffeensis for internalization and growth in THP-1 cells. Infect Immun 2002, 70(2):889.
76. Doyle CK, Zhang X, Popov VL, et al. An immunoreactive 38-kilodalton protein of Ehrlichia canis shares structural homology and iron-binding capacity with the ferric ion-binding protein family. Infect Immun 2005, 73(1):62.
77. Park J, Rikihisa Y l-Arginine-dependent killing of intracellular Ehrlichia risticii by macrophages treated with gamma interferon. Infect Immun 1992, 60(9):3504.
78. Zhang JZ, Sinha M, Luxon BA, et al. Survival strategy of obligately intracellular Ehrlichia chaffeensis: novel modulation of immune response and host cell cycles. Infect Immun 2004, 72(1):498.
79. Wakeel A, Kuriakose JA, McBride JW An Ehrlichia chaffeensis tandem repeat protein interacts with multiple host targets involved in cell signaling, transcriptional regulation, and vesicle trafficking. Infect Immun 2009, 77(5):1734.
80. Lee EH, Rikihisa Y Absence of tumor necrosis factor alpha, interleukin-6 (IL-6), and granulocyte-macrophage colony-stimulating factor expression but presence of IL-1beta, IL-8, and IL-10 expression in human monocytes exposed to viable or killed Ehrlichia chaffeensis. Infect Immun 1996, 64(10):4211.
81. Lin M, Rikihisa Y Ehrlichia chaffeensis downregulates surface Toll-like receptors 2/4, CD14 and transcription factor PU.1 and inhibits lipopolysaccharide activation of NF-kappa B, ERK 1/2 and p38 MAPK in host monocytes. Cell Microbiol 2004, 6(2):175.
82. Harrus S, Waner T, Friedmann-Morvinski D, et al. Down-regulation of MHC class II receptors of DH82 cells, following infection with Ehrlichia canis. Vet Immunol Immunopathol 2003, 96(3-4):239.
83. Li JS, Chu F, Reilly A, et al. Antibodies highly effective in SCID mice during infection by the intracellular bacterium Ehrlichia chaffeensis are of picomolar affinity and exhibit preferential epitope and isotype utilization. J Immunol 2002, 169(3):1419.
84. Ganta RR, Wilkerson MJ, Cheng C, et al. Persistent Ehrlichia chaffeensis infection occurs in the absence of functional major histocompatibility complex class II genes. Infect Immun 2002, 70(1):380.
85. Winslow GM, Yager E, Shilo K, et al. Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection. Infect Immun 2000, 68(4):2187.
86. Byrom B, Barbet AF, Obwolo M, et al. Cd8(+) T cell knockout mice are less susceptible to Cowdria ruminantium infection than athymic, CD4(+) T cell knockout, and normal C57Bl/6 mice. Vet Parasitol 2000, 93(2):159.
87. Byrom B, Obwolo M, Barbet AF, et al. A polarized Th1 type immune response to Cowdria ruminantium infection is detected in immune DBA/2 mice. J Parasitol 2000, 86(5):983.
88. Dawson JE, Candal FJ, George VG, et al. Human endothelial cells as an alternative to DH82 cells for isolation of Ehrlichia chaffeensis, E. canis, and Rickettsia rickettsii. Pathobiology 1993, 61(5-6):293.
89. Barnewall RE, Rikihisa Y Abrogation of gamma interferon-induced inhibition of Ehrlichia chaffeensis infection in human monocytes with iron-transferrin. Infect Immun 1994, 62(11):4804.
90. Brouqui P, Birg ML, Raoult D Cytopathic effect, plaque formation, and lysis of Ehrlichia chaffeensis grown on continuous cell lines. Infect Immun 1994, 62(2):405.
91. Chen SM, Popov VL, Feng HM, et al. Cultivation of Ehrlichia chaffeensis in mouse embryo, Vero, BGM, and L929 cells and study of Ehrlichia-induced cytopathic effect and plaque formation. Infect Immun 1995, 63(2):647.
92. Caldwell CW, Everett ED, McDonald G, et al. Apoptosis of gamma/delta T cells in human ehrlichiosis. Am J Clin Pathol 1996, 105(5):640.
93. Bakken JS, Krueth J, Wilson-Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 1996, 275(3):199.
94. Standaert SM, Yu T, Scott MA, et al. Primary isolation of Ehrlichia chaffeensis from patients with febrile illnesses: clinical and molecular characteristics. J Infect Dis 2000, 181(3):1082.
95. Everett ED, Evans KA, Henry RB, et al. Human ehrlichiosis in adults after tick exposure. Diagnosis using polymerase chain reaction. Ann Intern Med 1994, 120(9):730.
96. Steiert JG, Gilfoy F Infection rates of Amblyomma americanum and Dermacentor variabilis by Ehrlichia chaffeensis and Ehrlichia ewingii in southwest Missouri. Vector-Borne Zoonotic Dis 2002, 2(2):53.
97. Anziani OS, Ewing SA, Barker RW Experimental transmission of a granulocytic form of the tribe Ehrlichieae by Dermacentor variabilis and Amblyomma americanum to dogs. Am J Vet Res 1990, 51(6):929.
98. Yabsley MJ, Varela AS, Tate CM, et al. Ehrlichia ewingii infection in white-tailed deer (Odocoileus virginianus). Emerg Infect Dis 2002, 8(7):668.
99. Liddell AM, Stockham SL, Scott MA, et al. Predominance of Ehrlichia ewingii in Missouri dogs. J Clin Microbiol 2003, 41(10):4617.
100. Gusa AA, Buller RS, Storch GA, et al. Identification of a p28 gene in Ehrlichia ewingii: evaluation of gene for use as a target for a species-specific PCR diagnostic assay. J Clin Microbiol 2001, 39(11):3871.
101. Zhi N, Ohashi N, Tajima T, et al. Transcript heterogeneity of the p44 multigene family in a human granulocytic ehrlichiosis agent transmitted by ticks. Infect Immun 2002, 70(3):1175.
102. Barbet AF, Meeus PF, Belanger M, et al. Expression of multiple outer membrane protein sequence variants from a single genomic locus of Anaplasma phagocytophilum. Infect Immun 2003, 71(4):1706.
103. Dunning Hotopp JC, Lin M, Madupu R, et al. Comparative genomics of emerging human ehrlichiosis agents. PLoS Genet 2006, 2(2):e21.
104. Barbet AF, Lundgren AM, Alleman AR, et al. Structure of the expression site reveals global diversity in msp2 (p44) variants in Anaplasma phagocytophilum. Infect Immun 2006, 74(11):6429.
105. Park J, Choi KS, Dumler JS Major surface protein 2 of Anaplasma phagocytophilum facilitates adherence to granulocytes. Infect Immun 2003, 71(7):4018.
106. Herron MJ, Nelson CM, Larson J, et al. Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the p-selectin ligand, PSGL-1. Science 2000, 288(5471):1653.
107. Carlyon JA, Akkoyunlu M, Xia L, et al. Murine neutrophils require alpha1,3-fucosylation but not PSGL-1 for productive infection with Anaplasma phagocytophilum. Blood 2003, 102(9):3387.
108. Caturegli P, Asanovich KM, Walls JJ, et al. Anka: an Ehrlichia phagocytophila group gene encoding a cytoplasmic protein antigen with ankyrin repeats. Infect Immun 2000, 68(9):5277.
109. Lin M, den Dulk-Ras A, Hooykaas PJ, et al. Anaplasma phagocytophilum AnkA secreted by type IV secretion system is tyrosine phosphorylated by Abl-1 to facilitate infection. Cell Microbiol 2007, 9(11):2644.
110. Park J, Kim KJ, Choi KS, et al. Anaplasma phagocytophilum AnkA binds to granulocyte DNA and nuclear proteins. Cell Microbiol 2004, 6(8):743.
111. Garcia-Garcia JC, Barat NC, Trembley SJ, et al. Epigenetic silencing of host cell defense genes enhances intracellular survival of the rickettsial pathogen Anaplasma phagocytophilum. PLoS Pathog 2009, 5(6). e1000488.
112. Garcia-Garcia JC, Rennoll-Bankert KE, Pelly S, et al. Silencing of host cell cybb gene expression by the nuclear effector AnkA of the intracellular pathogen Anaplasma phagocytophilum. Infect Immun 2009, 77(6):2385.
113. Bakken JS, Dumler S Human granulocytic anaplasmosis. Infect Dis Clin North Am 2008, 22(3):433.
114. Pancholi P, Kolbert CP, Mitchell PD, et al. Ixodes dammini as a potential vector of human granulocytic ehrlichiosis. J Infect Dis 1995, 172(4):1007.
115. Magnarelli LA, Stafford KC, Mather TN, et al. Hemocytic rickettsia-like organisms in ticks: serologic reactivity with antisera to ehrlichiae and detection of DNA of agent of human granulocytic ehrlichiosis by PCR. J Clin Microbiol 1995, 33(10):2710.
116. Walls JJ, Greig B, Neitzel DF, et al. Natural infection of small mammal species in Minnesota with the agent of human granulocytic ehrlichiosis. J Clin Microbiol 1997, 35(4):853.
117. Goethert HK, Telford SR Enzootic transmission of the agent of human granulocytic ehrlichiosis among cottontail rabbits. Am J Trop Med Hyg 2003, 68(6):633.
118. Levin ML, Nicholson WL, Massung RF, et al. Comparison of the reservoir competence of medium-sized mammals and Peromyscus leucopus for Anaplasma phagocytophilum in Connecticut. Vector-Borne Zoonotic Dis 2002, 2(3):125.
119. Alberdi MP, Walker AR, Urquhart KA Field evidence that roe deer (Capreolus capreolus) are a natural host for Ehrlichia phagocytophila. Epidemiol Infect 2000, 124(2):315.
120. Aguero-Rosenfeld ME, Horowitz HW, Wormser GP, et al. Human granulocytic ehrlichiosis: a case series from a medical center in New York state. Ann Intern Med 1996, 125(11):904.
121. Nadelman RB, Horowitz HW, Hsieh TC, et al. Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N Engl J Med 1997, 337(1):27.
122. Moss WJ, Dumler JS Simultaneous infection with Borrelia burgdorferi and human granulocytic ehrlichiosis. Pediatr Infect Dis J 2003, 22(1):91.
123. Bjoersdorff A, Wittesjo B, Berglun J, et al. Human granulocytic ehrlichiosis as a common cause of tick-associated fever in southeast Sweden: Report from a prospective clinical study. Scand J Infect Dis 2002, 34(3):187.
124. Thompson C, Spielman A, Krause PJ Coinfecting deer-associated zoonoses: Lyme disease, babesiosis, and ehrlichiosis. Clin Infect Dis 2001, 33(5):676.
125. IJdo JW, Meek JI, Cartter ML, et al. The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: human granulocytic ehrlichiosis. J Infect Dis 2000, 181(4):1388.
126. Gardner SL, Holman RC, Krebs JW, et al. National surveillance for the human ehrlichioses in the United States, 1997-2001, and proposed methods for evaluation of data quality. Ann N Y Acad Sci 2003, 990:80.
127. Bakken JS, Goellner P, Van Etten M, et al. Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin. Clin Infect Dis 1998, 27(6):1491.
128. Aguero-Rosenfeld ME, Donnarumma L, Zentmaier L, et al. Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J Clin Microbiol 2002, 40(7):2612.
129. Cizman M, Avsic-Zupanc T, Petrovec M, et al. Seroprevalence of ehrlichiosis, Lyme borreliosis and tick-borne encephalitis infections in children and young adults in Slovenia. Wien Klin Wochenschr 2000, 112(19):842.
130. Walder G, Tiwald G, Dierich MP, et al. Serological evidence for human granulocytic ehrlichiosis in western Austria. Eur J Clin Microbiol Infect Dis 2003, 22(9):543.
131. Courtney JW, Dryden RL, Montgomery J, et al. Molecular characterization of Anaplasma phagocytophilum and Borrelia burgdorferi in Ixodes scapularis ticks from Pennsylvania. J Clin Microbiol 2003, 41(4):1569.
132. Chang YF, Novosel V, Dubovi E, et al. Experimental infection of the human granulocytic ehrlichiosis agent in horses. Vet Parasitol 1998, 78(2):137.
133. Kramer VL, Randolph MP, Hui LT, et al. Detection of the agents of human ehrlichioses in ixodid ticks from California. Am J Trop Med Hyg 1999, 60(1):62.
134. Lee SO, Na DK, Kim CM, et al. Identification and prevalence of Ehrlichia chaffeensis infection in Haemaphysalis longicornis ticks from Korea by PCR, sequencing and phylogenetic analysis based on 16S rRNA gene. J Vet Sci 2005, 6(2):151.
135. Christova I, Schouls L, van De Pol I, et al. High prevalence of granulocytic ehrlichiae and Borrelia burgdorferi sensu lato in Ixodes ricinus ticks from Bulgaria. J Clin Microbiol 2001, 39(11):4172.
136. Holden K, Boothby JT, Anand S, et al. Detection of Borrelia burgdorferi, Ehrlichia chaffeensis, and Anaplasma phagocytophilum in ticks (Acari: Ixodidae) from a coastal region of California. J Med Entomol 2003, 40(4):534.
137. Bown KJ, Begon M, Bennett M, et al. Seasonal dynamics of Anaplasma phagocytophila in a rodent-tick (Ixodes trianguliceps) system, United Kingdom. Emerg Infect Dis 2003, 9(1):63.
138. Blanco JR, Oteo JA Human granulocytic ehrlichiosis in Europe. Clin Microbiol Infect 2002, 8(12):763.
139. Hardalo CJ, Quagliarello V, Dumler JS Human granulocytic ehrlichiosis in Connecticut: report of a fatal case. Clin Infect Dis 1995, 21(4):910.
140. Wong S, Grady LJ Ehrlichia infection as a cause of severe respiratory distress. N Engl J Med 1996, 334(4):273.
141. Shea KW, Calio AJ, Klein NC, et al. Ehrlichia equi infection associated with rhabdomyolysis. Clin Infect Dis 1996, 22(3):605.
142. Low A, Turett G Human granulocytic ehrlichiosis presenting as acute abdomen in an adult. Clin Infect Dis 2003, 37(10):1397.
143. Gershel JC Human granulocytic ehrlichiosis presenting as abdominal pain. Pediatrics 2000, 106(3):602.
144. Lee FS, Chu FK, Tackley M, et al. Human granulocytic ehrlichiosis presenting as facial diplegia in a 42-year-old woman. Clin Infect Dis 2000, 31(5):1288.
145. Horowitz HW, Marks SJ, Weintraub M, et al. Brachial plexopathy associated with human granulocytic ehrlichiosis. Neurology 1996, 46(4):1026.
146. Bakken JS, Erlemeyer SA, Kanoff RJ, et al. Demyelinating polyneuropathy associated with human granulocytic ehrlichiosis. Clin Infect Dis 1998, 27(5):1323.
147. Lepidi H, Bunnell JE, Martin ME, et al. Comparative pathology, and immunohistology associated with clinical illness after Ehrlichia phagocytophila-group infections. Am J Trop Med Hyg 2000, 62(1):29.
148. Klein MB, Hu S, Chao CC, et al. The agent of human granulocytic ehrlichiosis induces the production of myelosuppressing chemokines without induction of proinflammatory cytokines. J Infect Dis 2000, 182(1):200.
149. Park J, Choi KS, Grab DJ, et al. Divergent interactions of Ehrlichia chaffeensis- and Anaplasma phagocytophilum-infected leukocytes with endothelial cell barriers. Infect Immun 2003, 71(12):6728.
150. Choi KS, Garyu J, Park J, et al. Diminished adhesion of Anaplasma phagocytophilum-infected neutrophils to endothelial cells is associated with reduced expression of leukocyte surface selectin. Infect Immun 2003, 71(8):4586.
151. Banerjee R, Anguita J, Roos D, et al. Cutting edge: Infection by the agent of human granulocytic ehrlichiosis prevents the respiratory burst by down-regulating gp91phox. J Immunol 2000, 164(8):3946.
152. Yoshiie K, Kim HY, Mott J, et al. Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Infect Immun 2000, 68(3):1125.
153. IJdo JW, Mueller AC Neutrophil NADPH oxidase is reduced at the Anaplasma phagocytophilum phagosome. Infect Immun 2004, 72(9):5392.
154. Choi KS, Scorpio DG, Dumler JS Anaplasma phagocytophilum ligation to Toll-like receptor (TLR) 2, but not to TLR4, activates macrophages for nuclear factor-kappa B nuclear translocation. J Infect Dis 2004, 189(10):1921.
155. Pedra JH, Sutterwala FS, Sukumaran B, et al. Asc/pycard and caspase-1 regulate the IL-18/IFN-gamma axis during Anaplasma phagocytophilum infection. J Immunol 2007, 179(7):4783.
156. Pedra JH, Tao J, Sutterwala FS, et al. IL-12/23p40-dependent clearance of Anaplasma phagocytophilum in the murine model of human anaplasmosis. FEMS Immunol Med Microbiol 2007, 50(3):401.
157. Browning MD, Garyu JW, Dumler JS, et al. Role of reactive nitrogen species in development of hepatic injury in a C57Bl/6 mouse model of human granulocytic anaplasmosis. Comp Med 2006, 56(1):55.
158. IJdo JW, Carlson AC, Kennedy EL Anaplasma phagocytophilum AnkA is tyrosine-phosphorylated at EPIYA motifs and recruits SHP-1 during early infection. Cell Microbiol 2007, 9(5):1284.
159. Bakken JS, Haller I, Riddell D, et al. The serological response of patients infected with the agent of human granulocytic ehrlichiosis. Clin Infect Dis 2002, 34(1):22.
160. Aguero-Rosenfeld ME Diagnosis of human granulocytic ehrlichiosis: state of the art. Vector-Borne Zoonotic Dis 2002, 2(4):233.
161. Edelman DC, Dumler JS Evaluation of an improved PCR diagnostic assay for human granulocytic ehrlichiosis. Mol Diagn 1996, 1(1):41.
162. Misao T, Kobayashi Y Studies on infectious mononucleosis (glandular fever). I. Isolation of etiologic agent from blood, bone marrow, and lymph node of a patient with infectious mononucleosis by using mice. Kyushu J Med Sci 1955, 6:145.
163. Tachibana N Sennetsu fever: the disease, diagnosis, and treatment. Microbiology 1986 1986, 205. ASM Press, Washington, DC. L. Lieve (Ed.).
164. Madigan JE, Pusterla N, Johnson E, et al. Transmission of Ehrlichia risticii, the agent of Potomac horse fever, using naturally infected aquatic insects and helminth vectors: preliminary report. Equine Vet J 2000, 32(4):275.
165. Pusterla N, Johnson EM, Chae JS, et al. Digenetic trematodes, Acanthatrium sp. and Lecithodendrium sp., as vectors of Neorickettsia risticii, the agent of Potomac horse fever. J Helminthol 2003, 77(4):335.
166. Brouqui P, Raoult D In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis. Antimicrob Agents Chemother 1992, 36(12):2799.
167. Klein MB, Nelson CM, Goodman JL Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins. Antimicrob Agents Chemother 1997, 41(1):76.
168. Maurin M, Bakken JS, Dumler JS Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States. Antimicrob Agents Chemother 2003, 47(1):413.
169. Buitrago MI, Ijdo JW, Rinaudo P, et al. Human granulocytic ehrlichiosis during pregnancy treated successfully with rifampin. Clin Infect Dis 1998, 27(1):213.
170. Krause PJ, Corrow CL, Bakken JS Successful treatment of human granulocytic ehrlichiosis in children using rifampin. Pediatrics 2003, 112(3 Pt 1):e252.
171. Maurin M, Abergel C, Raoult D DNA gyrase-mediated natural resistance to fluoroquinolones in Ehrlichia spp. Antimicrob Agents Chemother 2001, 45(7):2098.
172. Wormser GP, Filozov A, Telford SR, et al. Dissociation between inhibition and killing by levofloxacin in human granulocytic anaplasmosis. Vector-Borne Zoonotic Dis 2006, 6(4):388.
173. Katavolos P, Armstrong PM, Dawson JE, et al. Duration of tick attachment required for transmission of granulocytic ehrlichiosis. J Infect Dis 1998, 177(5):1422.
174. Hodzic E, Borjesson DL, Feng S, et al. Acquisition dynamics of Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis at the host-vector interface. Vector-Borne Zoonotic Dis 2001, 1(2):149.
175. des Vignes F, Piesman J, Heffernan R, et al. Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs. J Infect Dis 2001, 183(5):773.
176. Charlat S, Hurst GD, Mercot H Evolutionary consequences of Wolbachia infections. Trends Genet 2003, 19(4):217.
177. Turner JD, Langley RS, Johnston KL, et al. Wolbachia lipoprotein stimulates innate and adaptive immunity through Toll-like receptors 2 and 6 to induce disease manifestations of filariasis. J Biol Chem 2009, 284(33):22364.
178. Shakya S, Bajpai P, Sharma S, et al. Prior killing of intracellular bacteria Wolbachia reduces inflammatory reactions and improves antifilarial efficacy of diethylcarbamazine in rodent model of Brugia malayi. Parasitol Res 2008, 102(5):963.
179. Hoerauf A Filariasis: new drugs and new opportunities for lymphatic
180. Eng TR, Harkess JR, Fishbein DB, et al. Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988. JAMA 1990, 264(17):2251.
181. Olano JP, Hogrefe W, Seaton B, et al. Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol 2003, 10(5):891.
182. Hamburg BJ, Storch GA, Micek ST, et al. The importance of early treatment with doxycycline in human ehrlichiosis. Medicine (Baltimore) 2008, 87(2):53.
183. Schutze GE, Buckingham SC, Marshall GS, et al. Human monocytic ehrlichiosis in children. Pediatr Infect Dis J 2007, 26(6):475.
184. Thomas LD, Hongo I, Bloch KC, et al. Human ehrlichiosis in transplant recipients. Am J Transplant 2007, 7(6):1641.
185. Grzeszczuk A, Ziarko S, Kovalchuk O, et al. Etiology of tick-borne febrile illnesses in adult residents of north-eastern Poland: Report from a prospective clinical study. Int J Med Microbiol 2006, 296(suppl 40):242.
186. Lotric-Furlan S, Petrovec M, Avsic-Zupanc T, et al. Human granulocytic ehrlichiosis in Slovenia. Ann N Y Acad Sci 2003, 990:279.
187. Belongia EA, Gale CM, Reed KD, et al. Population-based incidence of human granulocytic ehrlichiosis in northwestern Wisconsin, 1997-1999. J Infect Dis 2001, 184(11):1470.
188. Belongia EA, Reed KD, Mitchell PD, et al. Clinical and epidemiological features of early Lyme disease and human granulocytic ehrlichiosis in Wisconsin. Clin Infect Dis 1999, 29(6):1472.
189. Wallace BJ, Brady G, Ackman DM, et al. Human granulocytic ehrlichiosis in New York. Arch Intern Med 1998, 158(7):769.
190. Lotric-Furlan S, Petrovec M, Avsic-Zupanc T, et al. Comparison of patients fulfilling criteria for confirmed and probable human granulocytic ehrlichiosis. Scand J Infect Dis 2004, 36(11-12):817.
191. Bakken JS, Dumler JS Clinical diagnosis and treatment of human granulocytotropic anaplasmosis. Ann N Y Acad Sci 2006, 1078:236.
192. Walder G, Fuchs D, Sarcletti M, et al. Human granulocytic anaplasmosis in Austria: epidemiological, clinical, and laboratory findings in five consecutive patients from Tyrol, Austria. Int J Med Microbiol 2006, 296(suppl 40):297.